Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -20.33% is 20% above its 5-year average of -25.30%, around the middle of its 5-year range (-35.08%–-12.10%).
11.76% above its 12-month average of -23.04%.
Reported quarterly return on assets; no daily interpolation. Q3 FY2026 (2026-06-30): -5.21%.
RETURN ON ASSETS (ROA)
-20.33%
RETURN ON ASSETS (ROA) AVG TTM
-23.04%
RETURN ON ASSETS (ROA) AVG 3Y
-23.77%
RETURN ON ASSETS (ROA) AVG 5Y
-25.30%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+11.76%
CURRENT VS 3Y AVG
+14.48%
CURRENT VS 5Y AVG
+19.66%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.27%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+36.99%
vs the sector median at left
Twist Bioscience Corporation
Market Cap
$10.40B
Return on Assets (ROA)
-20.33%
TTM Avg
-23.04%
3Y Avg
-23.77%
5Y Avg
-25.30%
Market Cap
$10.31B
Return on Assets (ROA)
9.76%
TTM Avg
6.05%
3Y Avg
5.92%
5Y Avg
6.23%
Market Cap
$10.24B
Return on Assets (ROA)
-7.29%
TTM Avg
-12.03%
3Y Avg
-16.66%
5Y Avg
-21.79%
Market Cap
$10.19B
Return on Assets (ROA)
-0.04%
TTM Avg
5.29%
3Y Avg
6.08%
5Y Avg
6.13%
Market Cap
$10.15B
Return on Assets (ROA)
-157.89%
TTM Avg
-89.00%
3Y Avg
-102.14%
5Y Avg
-97.13%
Market Cap
$10.13B
Return on Assets (ROA)
6.44%
TTM Avg
6.68%
3Y Avg
6.69%
5Y Avg
12.75%
Market Cap
$10.72B
Return on Assets (ROA)
9.58%
TTM Avg
8.61%
3Y Avg
6.84%
5Y Avg
6.99%
Market Cap
$10.03B
Return on Assets (ROA)
6.59%
TTM Avg
6.34%
3Y Avg
6.05%
5Y Avg
6.29%
Market Cap
$10.87B
Return on Assets (ROA)
0.62%
TTM Avg
5.35%
3Y Avg
3.84%
5Y Avg
4.82%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Twist Bioscience Corporation (TWST) | $10.40B | -20.33% | -23.04% | -23.77% | -25.30% |
| Globus Medical, Inc. (GMED)vs › | $10.31B | 9.76% | 6.05% | 5.92% | 6.23% |
| 10x Genomics, Inc. (TXG)vs › | $10.24B | -7.29% | -12.03% | -16.66% | -21.79% |
| Molina Healthcare, Inc. (MOH)vs › | $10.19B | -0.04% | 5.29% | 6.08% | 6.13% |
| ImmunityBio, Inc. (IBRX)vs › | $10.15B | -157.89% | -89.00% | -102.14% | -97.13% |
| Align Technology, Inc. (ALGN)vs › | $10.13B | 6.44% | 6.68% | 6.69% | 12.75% |
| Universal Health Services, Inc. (UHS)vs › | $10.72B | 9.58% | 8.61% | 6.84% | 6.99% |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 6.59% | 6.34% | 6.05% | 6.29% |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.87B | 0.62% | 5.35% | 3.84% | 4.82% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | 2.17% | -6.26% | -11.14% | 1.46% |
ROA
-20.3%
ROE
-30.7%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-09-30 | -12.10% |
| 2024-09-30 | -33.98% |
| 2023-09-30 | -26.35% |
| 2022-09-30 | -22.66% |
| 2021-09-30 | -21.66% |
| 2020-09-30 | -35.08% |
| 2019-09-30 | -57.58% |
| 2018-09-30 | -61.52% |
| 2017-09-30 | -69.24% |
| 2016-09-30 | -57.66% |
